Hypertension Trial, Recruiting (NCT05325437)

Hypertension Trial, Recruiting NCT05325437 Sponsor: Northern Jiangsu People's Hospital Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT05325437 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with cirrhosis (scarring of the liver) from any cause, confirmed by a doctor's assessment, imaging, or tissue sample
People who have an enlarged spleen that is causing a reduction in blood cells (a condition where the spleen destroys blood cells too quickly)
People who have experienced bleeding from enlarged veins in the food pipe or stomach (caused by liver disease)
People who have given their informed consent to take part in the study

Who may not be able to join:

People who have liver cancer or any other type of cancer
People whose liver disease has been rated as severely advanced (classified as Child-Pugh grade C — confirm with trial site if unsure what this means)
People who have recently had a peptic ulcer (a sore in the lining of the stomach or digestive tract)
People who have previously had a bleeding stroke (a type of stroke caused by bleeding in the brain)
People who are pregnant
People who have high blood pressure that is not being controlled with treatment
People who have HIV infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guo-Qing Jiang, MD, Clinical Medical College of Yangzhou University

Phone: +8651487373272

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05325437

Sponsor: Northern Jiangsu People's Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: +8651487373272

More information: https://clinicaltrials.gov/study/NCT05325437

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with cirrhosis (scarring of the liver) from any cause, confirmed by a doctor's assessment, imaging, or tissue sample
People who have an enlarged spleen that is causing a reduction in blood cells (a condition where the spleen destroys blood cells too quickly)
People who have experienced bleeding from enlarged veins in the food pipe or stomach (caused by liver disease)
People who have given their informed consent to take part in the study

Who may not be able to join:

People who have liver cancer or any other type of cancer
People whose liver disease has been rated as severely advanced (classified as Child-Pugh grade C — confirm with trial site if unsure what this means)
People who have recently had a peptic ulcer (a sore in the lining of the stomach or digestive tract)
People who have previously had a bleeding stroke (a type of stroke caused by bleeding in the brain)
People who are pregnant
People who have high blood pressure that is not being controlled with treatment
People who have HIV infection

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Northern Jiangsu People's Hospital

Registry

ClinicalTrials.gov

Start date

1 March 2022

Est. completion

31 July 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Liver reserve function ICG-K at 3 months after surgery.; Liver reserve function ICG-K at 6 months after surgery.; Liver reserve function ICG-K at 12 months after surgery.; Liver reserve function ICG-K at 24 months after surgery.; Liver reserve function ICG-R 15 at 3 months after surgery.; Liver reserve function ICG-R 15 at 6 months after surgery.; Liver reserve function ICG-R 15 at 12 months after surgery.; Liver reserve function ICG-R 15 at 24 months after surgery.; Liver reserve function ICG-T/2 at 3 months after surgery.; Liver reserve function ICG-T/2 at 6 months after surgery.; Liver rese...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov